Panaxia Labs Israel Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was ILS 83.6 million compared to ILS 60.75 million a year ago. Net loss was ILS 21.38 million compared to ILS 35.9 million a year ago.

Basic loss per share from continuing operations was ILS 1.5 compared to ILS 3.2 a year ago.